Caribou Biosciences (CRBU) Current Deferred Revenue (2020 - 2026)
Caribou Biosciences (CRBU) recorded Current Deferred Revenue of $372,000 in Q2 2026, down 86.9% from $2.83 million a year earlier and down 62.6% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences reported Current Deferred Revenue of $1.9 million, down 39.4% from FY2024.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of 106.9% (FY2020 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $3.13 million in FY2024 (+9.9%), $2.85 million in FY2023 (-71.3%), $9.94 million in FY2022 (+14.2%) and $8.7 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Current Deferred Revenue since Q1 2022.
- On a year-over-year basis, Current Deferred Revenue has declined for four consecutive quarters, with an average decline of 25.3% over the last eight quarters.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 14.2% in Q4 2022, against a decline of 86.9% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $994,000 (Q1 2026), $1.9 million (Q4 2025) and $2.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Caribou Biosciences | 134.61 Mn | -381.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 372,000.00 |
| Mar 31, 2026 | 994,000.00 |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 12.96 Mn |
| Mar 31, 2023 | 10.88 Mn |
| Dec 31, 2022 | 9.94 Mn |
| Sep 30, 2022 | 12.04 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 8.70 Mn |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 50,000.00 |
API Access
Caribou Biosciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();